1,5-anhydroglucitol has been researched along with Cancer of Pancreas in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuma, T; Goto, A; Hidaka, A; Hirata, Y; Inoue, M; Iwasaki, M; Kobayashi, T; Nakagawa, T; Nishiumi, S; Sawada, N; Shimazu, T; Tsugane, S; Yamaji, T; Yamanaka, K; Yoshida, M | 1 |
Ichiyanagi, K; Inoue, T; Ogata, N; Sakai, T; Yamanouchi, T | 1 |
Inoue, T; Kashiwabara, A; Kawasaki, T; Muraoka, H; Ogata, E; Ogata, N; Yamanouchi, T; Yoshimura, T | 1 |
3 other study(ies) available for 1,5-anhydroglucitol and Cancer of Pancreas
Article | Year |
---|---|
Metabolome analysis for pancreatic cancer risk in nested case-control study: Japan Public Health Center-based prospective Study.
Topics: Adult; Aged; Asparagine; Case-Control Studies; Deoxyglucose; Female; Humans; Logistic Models; Male; Metabolome; Methionine; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Risk | 2018 |
1,5-Anhydroglucitol stimulates insulin release in insulinoma cell lines.
Topics: Animals; Carbohydrates; Cell Division; Cell Line, Tumor; Deoxyglucose; Humans; Insulin; Insulin Secretion; Insulinoma; Pancreatic Neoplasms; Xylitol | 2003 |
Transport of 1,5-anhydro-D-glucitol into insulinoma cells by a glucose-sensitive transport system.
Topics: Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Drug; Glucose; Humans; Insulinoma; Kinetics; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Temperature; Tritium; Tumor Cells, Cultured | 2000 |